about
Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new dataIs surgery still the optimal treatment for stage I non-small cell lung cancer?Staging lymph node metastases from lung cancer in the mediastinumSurgical management of oligometastatic non-small cell lung cancerLongitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancersA laboratory prognostic index model for patients with advanced non-small cell lung cancerPhotoacoustic Spectroscopy for the Determination of Lung Cancer Biomarkers-A Preliminary Investigation.In-silico study of small cell lung cancer based on protein structure and function: A new approach to mimic biological system.Incidental detection by computed tomography is an independent prognostic factor for survival in patients operated for nonsmall cell lung carcinomaRelationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer.Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and designA six-month study of pulmonary cancer in Albanian womenThe distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy.Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in CanadaOverexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survivalPhotodynamic therapy of disseminated non-small cell lung carcinoma in a murine modelThe cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.Staging of lung cancer in a tertiary care setting in Sri Lanka, using TNM 7th edition. A comparison against TNM6Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancerWnt signaling pathway pharmacogenetics in non-small cell lung cancerVaried pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysisHigh Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.High incidence of ischemic stroke occurrence in irradiated lung cancer patients: a population-based surgical cohort study.How close are we to customizing chemotherapy in early non-small cell lung cancer?Functional CT imaging techniques for the assessment of angiogenesis in lung cancer.Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer.Large cell neuroendocrine carcinoma: topic review and a unique case of metastasis to the mandible.Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.Parenchymal preserving anatomic resections result in less pulmonary function loss in patients with Stage I non-small cell lung cancerPrognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.A pilot study using low-dose Spectral CT and ASIR (Adaptive Statistical Iterative Reconstruction) algorithm to diagnose solitary pulmonary nodules.Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CTPET/CT in the staging of the non-small-cell lung cancer.The 7th lung cancer TNM classification and staging system: Review of the changes and implications.Surgical results and staging of non-small cell lung cancer with interlobar pleural invasionPredicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunitiesHuman leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer
P2860
Q24633254-9AFA1A37-7749-4434-AB7E-2B80AFE652DEQ26749371-E987C8DE-A441-4589-8BE5-517F00C36035Q26863443-3CC368BC-6D19-4434-8159-95EC08C5B552Q28067370-C7192E8A-7BE4-41A5-8C1E-99B8B998CE50Q28387198-EFFD844A-3F48-44AC-BEF0-D2B8903D0852Q28542513-CF73CD6C-504B-463F-94E9-E906B0628D33Q30363643-527FFEBD-0740-476C-AE75-8EA2110D81C2Q30378513-1B9480A3-A201-4163-8C8E-D15583F34DD6Q33607796-9F027156-E4D8-43CA-9E41-0B415FBABAA6Q33614113-0086F116-1DE7-48CD-B91D-CAFEA1AA3B43Q33741041-43E079D8-48A8-4B25-A93A-253F535B268BQ33775344-D5C555B3-4F3D-4F63-BD46-41E4ED9E3BA2Q33829634-5A26791E-9D53-4539-81FD-0318B850215FQ33831950-0E913F73-4C26-4DC5-8EA9-5B11BD4EF6F3Q33966259-75A2C1CE-33C6-429B-9C40-F5042021B1D0Q34005116-27733007-E872-4F53-9E4B-D183D1DA644CQ34009639-FF8BCC0F-38B6-4C55-BB11-3871DF8377D0Q34068178-DDCE4861-4841-481C-BCB4-B87267DAD011Q34150080-B9F90E1B-F264-45C5-855A-2077D92CB44DQ34194383-E0C2B1A0-D81F-4147-8DEE-BAAD1D4585EDQ34465282-0040AB43-ED85-4891-B012-29498CC9FA01Q34543360-DBC5E48C-2F16-479F-AE19-181193B46212Q34941004-849A529D-7BCC-4698-923D-E768AA0C3810Q34956692-2C07AF1D-8447-41F4-8CC6-0102B3B445F9Q35141687-7698BBE2-AC3D-419F-9659-1B5E06FA6677Q35146944-575E24E2-A72D-4A2E-AA97-EB3F7F32EB4FQ35200388-41E8A0DB-C3AB-4AF5-A3A2-849CAE71DFBDQ35200620-5F5D5527-D798-4C07-9D9F-BC7E20101288Q35231995-93465D63-F331-492B-AD91-5812DFCA4ECCQ35233122-D52ED4DB-C60A-4BE2-BAFE-D6318BFA4CA1Q35245922-4F601BF0-00BF-4C42-85AE-47099747EC76Q35645484-A18140A1-E961-4624-9817-8787D484E58DQ35779042-EC4EA258-3078-4E36-A582-BD66F9327A06Q35843955-46D8024F-9D2E-47FA-BF99-AD02BF63390FQ35857826-A1F02DDD-26D1-442F-9DC6-62443BD27E73Q35941591-5CEA176C-D7F0-4E62-92EC-4272733BB402Q35957887-80798C6A-9C39-4E8A-B807-0B2448CD9FC3Q35961897-5B5CB513-7E4C-4DCF-A6EC-383B74EB0EDAQ35996028-EE5E67EB-9B25-4DEB-B65E-A03B689E7579Q36051715-717D0368-DF8D-43BD-86DD-7A2A17870C3A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The revised TNM staging system for lung cancer.
@ast
The revised TNM staging system for lung cancer.
@en
The revised TNM staging system for lung cancer.
@nl
type
label
The revised TNM staging system for lung cancer.
@ast
The revised TNM staging system for lung cancer.
@en
The revised TNM staging system for lung cancer.
@nl
prefLabel
The revised TNM staging system for lung cancer.
@ast
The revised TNM staging system for lung cancer.
@en
The revised TNM staging system for lung cancer.
@nl
P1476
The revised TNM staging system for lung cancer
@en
P2093
John J Crowley
Peter Goldstraw
P577
2009-02-01T00:00:00Z